Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

Anderson, 2003, Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction, Heart Fail Rev, 8, 71, 10.1023/A:1022199021949

Archer, 1993, Measurement of nitric oxide in biological models, FASEB J, 7, 349, 10.1096/fasebj.7.2.8440411

Archer, 1998, Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension, Am J Respir Crit Care Med, 158, 1061, 10.1164/ajrccm.158.4.9802113

Bernstein, 1998, Nitric oxide synthase-containing neurons in human hypothalamus, Neuroscience, 83, 867, 10.1016/S0306-4522(97)00461-2

Blair, 1985, Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments, Am J Epidemiol, 122, 794, 10.1093/oxfordjournals.aje.a114163

Cicinelli, 1996, Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle, Fertil Steril, 6, 1036, 10.1016/S0015-0282(16)58706-8

Faulx, 2003, Detection of endothelial dysfunction with brachial artery ultrasound scanning, Am Heart J, 145, 943, 10.1016/S0002-8703(03)00097-8

Feron, 1999, Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase, J Clin Invest, 6, 897, 10.1172/JCI4829

Freedman, 1997, Nitric oxide released from activated platelets inhibits platelet recruitment, J Clin Invest, 100, 350, 10.1172/JCI119540

Freedman, 1998, Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes, Circulation, 98, 1481, 10.1161/01.CIR.98.15.1481

Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56

Hashimoto, 1990, Plasma tetrahydrobiopterin levels in patients with psychiatric disorders, Neuropsychobiology, 23, 140, 10.1159/000119441

Hingorani, 1999, A common variant of the endothelial nitric oxide synthase (Glu298/Asp) is a major risk factor for coronary artery disease in the UK, Circulation, 100, 1515, 10.1161/01.CIR.100.14.1515

Holven, 2001, Effect of folic acid treatment on endothelium-dependent vasodilatation and nitric oxide-derived end products in hyoperhomocysteinemic subjects, Am J Med, 119, 536, 10.1016/S0002-9343(01)00696-9

Ignarro, 1989, Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein, Circ Res, 65, 1, 10.1161/01.RES.65.1.1

Jaffrey, 1995, Nitric oxide, Annu Rev Cell Dev Biol, 11, 417, 10.1146/annurev.cb.11.110195.002221

Joynt, 2003, Depression and cardiovascular disease, Biol Psychiatry, 54, 248, 10.1016/S0006-3223(03)00568-7

Laghrissi-Thode, 1997, Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease, Biol Psychiatry, 42, 290, 10.1016/S0006-3223(96)00345-9

Landmesser, 2000, Endothelial dysfunction in hypercholesterolemia, Semin Thromb Hemost, 26, 529, 10.1055/s-2000-13209

Lara, 2003, Paroxetine-induced increase in metabolic end products of nitric oxide (NO), J Clin Psychopharm, 23, 641, 10.1097/01.jcp.0000085416.08426.1d

Lederbogen, 2001, Increased platelet aggregability in major depression?, Psychiatry Res, 102, 255, 10.1016/S0165-1781(01)00259-1

Le Mellédo, 2004, Selective serotonin reuptake inhibitor and myocardial infarction, Circulation, 109, E19, 10.1161/01.CIR.0000113707.06004.3B

Lespérance, 2002, Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction, Circulation, 105, 1049, 10.1161/hc0902.104707

Maeda, 2001, Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans, Life Sci, 69, 1005, 10.1016/S0024-3205(01)01192-4

Maher, 2002, Endothelium contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes, Diabetes, 51, 3517, 10.2337/diabetes.51.12.3517

Mangos, 2000, Cortisol inhibits cholinergic vasodilatation in the human forearm, Am J Hypertens, 13, 1155, 10.1016/S0895-7061(00)01201-2

Mehta, 1995, Identification of constitutive and inducible forms of nitric oxide synthase in human platelets, J Lab Clin Med, 125, 370

Moncada, 1993, Mechanisms of disease, N Engl J Med, 329, 2002

Musselman, 1996, Exaggerated platelet reactivity in major depression, Am J Psychiatry, 153, 1313, 10.1176/ajp.153.10.1313

Nemeroff, 2000, Are platelets the link between depression and ischemic heart disease?, Am Heart J, 140, S57, 10.1067/mhj.2000.109978

Node, 1997, Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults, Am J Cardiol, 79, 1538, 10.1016/S0002-9149(97)00189-6

Node, 1997, Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension, Hypertension, 30, 405, 10.1161/01.HYP.30.3.405

Perlmutter, 2000, Major depression as a risk factor for cardiovascular disease, Heart Dis, 2, 75

Plotsky, 1998, Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenocortical axis, Psychiatr Clin North Am, 21, 293, 10.1016/S0193-953X(05)70006-X

Pratt, 1996, Depression, psychotropic medication and risk of myocardial infarction, Circulation, 94, 3123, 10.1161/01.CIR.94.12.3123

Radomski, 1983, An improved method for washing of human platelets with prostacyclin, Thromb Res Suppl, 30, 383, 10.1016/0049-3848(83)90230-X

Radomski, 1987, Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium, Lancet, 2, 1057, 10.1016/S0140-6736(87)91481-4

Radomski, 1987, The antiaggregating properties of vascular endothelium, Br J Pharmacol, 92, 639, 10.1111/j.1476-5381.1987.tb11367.x

Radomski, 1990, An L-arginine/nitric oxide pathway present in human platelets regulates aggregation, Proc Natl Acad Sci U S A, 87, 1788, 10.1073/pnas.87.13.5193

Radomski, 1993, Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide, Cardiovasc Res, 27, 1580, 10.1093/cvr/27.7.1380

Rajagopalan, 2001, Abnormal brachial artery flow-mediated vasodilation in young adults with major depression, Am J Cardiol, 88, 196, 10.1016/S0002-9149(01)01623-X

Rapaport, 2001, Prevalence, recognition and treatment of comorbid depression and anxiety, J Clin Psychiatry, 62, 6

Rogers, 2002, Inhibitory effect of glucocorticoid on coronary artery endothelial function, Am J Physiol Heart Circ Physiol, 27, H1922, 10.1152/ajpheart.00364.2002

Rozanski, 1999, Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy, Circulation, 99, 2192, 10.1161/01.CIR.99.16.2192

Shimasaki, 1998, Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction, J Am Coll Cardiol, 31, 1506, 10.1016/S0735-1097(98)00167-3

Shimokawa, 1999, Primary dysfunction, J Mol Cell Cardiol, 31, 23, 10.1006/jmcc.1998.0841

Suzuki, 2001, Elevated plasma nitrate levels in depressive states, J Affect Dis, 63, 221, 10.1016/S0165-0327(00)00164-6

Szabo C (1998): Regulation of the expression of the inducible isoform of nitric oxide synthase by glucocorticoids. Ann N Y Acad Sci 851:336–341

Szabo, 1994, Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo, Proc Natl Acad Sci U S A, 91, 271, 10.1073/pnas.91.1.271

Tanaka, 1997, Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level, Clin Cardiol, 20, 361, 10.1002/clc.4960200412

van Amsterdam, 1999, Nitric oxide and biopterin in depression and stress, Psychiatry Res, 85, 33, 10.1016/S0165-1781(98)00140-1

Vandivier, 1999, Down-regulation of NO production by ibuprofen in human volunteers, J Pharmacol Exp Ther, 289, 1398

Ventura, 1998, Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P), Psychiatry Res, 79, 163, 10.1016/S0165-1781(98)00038-9

Verna, 2003, Endothelial function testing as a biomarker of vascular disease, Circulation, 108, 2054, 10.1161/01.CIR.0000089191.72957.ED

Viinikka, 1996, Nitric oxide as a challenge for the clinical chemistry laboratory, Scand J Clin Lab Invest, 56, 577, 10.3109/00365519609090591

Wallerath, 1999, Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension, Proc Natl Acad Sci U S A, 96, 13357, 10.1073/pnas.96.23.13357

Ware, 1993, Platelet-endothelium interactions, N Engl J Med, 328, 628, 10.1056/NEJM199303043280907

White, 1994, Platelets and atherosclerosis, Eur J Clin Invest, 24, 25, 10.1111/j.1365-2362.1994.tb02422.x

Xing, 2002, Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression, Schizophr Res, 58, 21, 10.1016/S0920-9964(01)00388-7